[Current situation and developmental trends in the field of thrombolytic agents].
D001230:Aspergillus / Q000201:enzymology; D001777:Blood Coagulation; D004789:Enzyme Activation; D005337:Fibrin / Q000378:metabolism; D005341:Fibrinolysin / Q000378:metabolism; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010447:Peptide Hydrolases / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism; D013300:Streptokinase / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy*; D014357:Trypsin / Q000494:pharmacology
D005343:Fibrinolytic Agents; D005337:Fibrin; D010958:Plasminogen; D010447:Peptide Hydrolases; D013300:Streptokinase; D014357:Trypsin; D005341:Fibrinolysin
Gegenwärtiger Stand und Entwicklungstendenzen auf dem Gebiet der Thrombolytika